Molecular Templates Layoffs - Molecular templates announced significant changes in its leadership, with multiple resignations from its board of directors and the resignation of dr. Eqrx has since effectively shut. It’s been an eventful year so far for molecular templates—and not in a good way. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. Molecular templates is fighting for survival. Molecular templates also announced a restructuring plan that includes reducing its current workforce as it continues to explore strategic alternatives. 84 employees were laid off in total from this layoff. It means that molecular templates paid off $27.5 million of its debt to k2, leaving an outstanding balance of around $10 million that will be paid off in the event of certain. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. (mtem) filed 1 warn layoff notice on apr 2023 in texas. ** shares of drug developer molecular templates mtem rise ~3% to $1.5 in extended trading ** company says it will reduce its workforce by ~60%, or 19 employees **. Molecular templates is fighting for survival. Other biotechs listing repeat cuts in 2023 alone are molecular templates, frequency therapeutics, eqrx and talaris therapeutics. Looking to focus on its core clinical development programs and extending its financial runway, molecular templates will be halving its headcount and letting go of a total of. Is overhauling a chunk of.
Molecular Templates Also Announced A Restructuring Plan That Includes Reducing Its Current Workforce As It Continues To Explore Strategic Alternatives.
Molecular templates is fighting for survival. Other biotechs listing repeat cuts in 2023 alone are molecular templates, frequency therapeutics, eqrx and talaris therapeutics. Looking to focus on its core clinical development programs and extending its financial runway, molecular templates will be halving its headcount and letting go of a total of. Is overhauling a chunk of.
** Shares Of Drug Developer Molecular Templates Mtem Rise ~3% To $1.5 In Extended Trading ** Company Says It Will Reduce Its Workforce By ~60%, Or 19 Employees **.
84 employees were laid off in total from this layoff. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. It means that molecular templates paid off $27.5 million of its debt to k2, leaving an outstanding balance of around $10 million that will be paid off in the event of certain. It’s been an eventful year so far for molecular templates—and not in a good way.
Molecular Templates Is Fighting For Survival.
(mtem) filed 1 warn layoff notice on apr 2023 in texas. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. Eqrx has since effectively shut. Molecular templates announced significant changes in its leadership, with multiple resignations from its board of directors and the resignation of dr.